Learn More
Prevalence of metabolic syndrome (MS) was estimated in 227 patients with schizophrenia. A total of 43.6% of patients fulfilled International Diabetes Federation (IDF) criteria and 44.5% met modified National Cholesterol Education Program Adult Treatment Panel-III (NCEP ATP- III) criteria of MS. Increased waist circumference was the most common abnormality(More)
Objective of this study was to compare the cost of care of schizophrenia estimated in the same catchment area separated by a decade. Cost of care of schizophrenia was estimated in 50 outpatients in 2001-2002 and 53 outpatients 2010-2011 using the same methodology along with structured assessments of psychopathology. Overall cost of care of schizophrenia has(More)
AIM To assess and compare the average annual the cost of illness of outpatients with bipolar disorder and schizophrenia. METHODS Cost of illness in 75 out-patients with bipolar disorder and 53 out-patients with schizophrenia was assessed over a 9-month period by using bottom-up approach. The cost of 9 months was annualized by dividing the 9 months cost by(More)
PURPOSE To study the prevalence of metabolic syndrome in patients with bipolar disorder. MATERIAL AND METHOD By using purposive random sampling 200 patients with bipolar disorder receiving treatment were evaluated for presence of metabolic syndrome using International Diabetes Federation (IDF) and modified National Cholesterol Education Program Adult(More)
PURPOSE OF REVIEW Recently, there has been much interest and rapid progress in understanding the neuropsychiatry of Parkinson's disease. This paper reviews the most important papers published during 2004 on dementia and cognitive impairment, depression and psychosis in Parkinson's disease. RECENT FINDINGS Many new studies of cognitive impairment and(More)
  • 1